Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea
US8524281B2 · kind B2 · utility
11Cited by
5References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 5, 2010 |
| Grant date | Sep 3, 2013 |
| Priority date | — |
| Expiry date | Nov 5, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an oral pharmaceutical formulation comprising coated spheroids of a kinase inhibitor such as neratinib, which formulation is designed to reduce or eliminate side effects associated with existing oral formulations of kinase inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.